Dr. Stefan Octavian Ciurea, MD

Dr. Ciurea practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Ciurea's NPI, 1710149752, was assigned on July 1, 2008. Dr. Ciurea graduated from University of Medicine and Pharmacy ‘Gr T Popa” Iasi in 1996. Dr. Ciurea holds Texas license 42260.

Dr. Ciurea's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Ciurea's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Ciurea is also affiliated with Hoag Hospital Newport Beach. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ciurea practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ciurea's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Ciurea is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ciurea's licenses on file in 5 states: Texas, California, Oklahoma, Illinois and Pennsylvania.

Dmand AI lists anemia, chronic anemia, chronic leukemia, immune deficiency disease, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Ciurea treats.

CMS data shows 306 Medicare services from Dr. Ciurea across 3 procedure codes in 2024, for 67 Medicare patients. Medicare paid $35,410 for them.

CMS counts 67 Medicare patients who saw Dr. Ciurea in 2024. The largest group is 65 to 74, with 42 patients. 69% of them have high blood pressure, and 55% have high cholesterol. 46% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ciurea's median patient age at 62, with 44% women.

In 2024, Dr. Ciurea wrote 624 Medicare Part D claims for 62 patients. 81% of them were for generic drugs. CMS names the drug for 412 of them, across 18 drugs with 11 or more claims each, at $636,015 in total drug cost. In 2023, CMS named 541 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ciurea for performance year 2024, reported through an alternative payment model (APM). Dr. Ciurea accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ciurea as offering telehealth.

Dmand AI links 169 papers to Dr. Ciurea, published from 2008 to 2025. 2017 was the busiest year, with 12. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Transplantation, Homologous. Dr. Ciurea has published most often in Biol Blood Marrow Transplant. Dr. Ciurea's most frequent co-authors are Richard E. Champlin, MD, Uday R. Popat, MD and Partow Kebriaei, MD.

CMS Open Payments shows 17 general payments to Dr. Ciurea from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Sobi, Inc paid the most, $5,088.

Dr. Ciurea graduated from University of Medicine and Pharmacy ‘Gr T Popa” Iasi in 1996.

Dr. Ciurea is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.